Dianthus Therapeutics (DNTH) Revenue (2022 - 2025)
Dianthus Therapeutics' quarterly Revenue came in at $396000.0 in Q3 2025, down 81.77% year-on-year from $2.2 million in Q3 2024, and up 105.18% quarter-over-quarter from $193000.0 in Q2 2025.
Dianthus Therapeutics has reported Revenue for 4 years, with the latest figure at $396000.0 in Q3 2025.
- For the quarter ending Q3 2025, Revenue fell 81.77% year-over-year to $396000.0; the trailing twelve-month figure through Sep 2025 stood at $3.1 million (down 41.61% YoY), and the FY2024 full-year result was $6.2 million, up 120.63% from the prior year.
- Revenue for Q3 2025 stood at $396000.0, up from $193000.0 in the prior quarter.
- The five-year high for Revenue was $2.2 million in Q3 2024, with the low at $193000.0 in Q2 2025.
- Average Revenue over 4 years is $1.0 million, with a median of $1.0 million recorded in 2023.
- Year-over-year, Revenue surged 211.27% in 2024 and tumbled 89.64% in 2025.
- Tracing DNTH's Revenue over 4 years: stood at $1.2 million in 2022, then slumped by 63.21% to $426000.0 in 2023, then surged by 211.27% to $1.3 million in 2024, then plunged by 70.14% to $396000.0 in 2025.
- The last three Revenue figures came in at $396000.0 (Q3 2025), $193000.0 (Q2 2025), and $1.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 874,000.00 |
| Dec 31, 2023 | 426,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 476,000.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 1.17 Mn |